期刊文献+

慢性特发性荨麻疹患者口服抗组胺药治疗依从性分析 被引量:2

Analysis of the compliance of oral antiallergics for treatment of chronic idiopathetic urticaria
下载PDF
导出
摘要 目的:了解慢性特发性荨麻疹患者口服抗组胺药治疗的依从性及影响因素。方法:将112例患者随机分为A、B两组,A组口服左西替利嗪片、酮替芬片和西咪替丁片;B组口服地氯雷他定片,两组患者均服药8周。采用自编问卷对每例患者进行调查。结果:平均服药依从率为68.75%。依从者治疗有效率为68.83%,不依从者有效率为31.43%,依从率和年龄、病程、治疗方案有显著性相关(P<0.05),与性别、文化程度无显著性关系(P>0.05)。不依从原因主要为患者对疾病危害性缺乏了解或担心副作用或认为已治愈自行停药。结论:慢性特发性荨麻疹患者口服抗组胺药治疗的依从性较低且其对疗效影响显著。年龄、病程和治疗方案对依从性有影响。 Objective: To understand the compliance and influence factor on chronic idiopathetie urticaria with oral antiallergies. Methods: 112 patients were randomly divided into A group and B group. Patients were treated with levocetirizine, ketotifen and cimitidine (A group) and desloratadine (B group), during the course of treatment for 8 weeks. Self-administered questionnaire was applied in the survey on every patient. Results :The average rate of compliance was 68.75%, the effect rate for those compliance with doctors' order was 68.83%, while it was only 31.43% for those noncompliant patients. It was found that the compliant rates were significantly correlated to ageing, the therapy scheme and course (P〈0.05), while no significant correlations were seen between male and female, culture degree (P〉0.05). Among the noncompl.iant ones, patients mainly did not understand hazardousness of chronic idiopathetic urticaria or patients were worried about the side effects of medicine or thought that they had already been cured. Conclusion: Our results showed that the compliance was low which exerted a significant influence on the curative effect of chronic idiopathetie urticaria patients. Factors as ageing, the therapy scheme and course has an influence on the compliant rate.
作者 龙晓燕 刘雄
出处 《华夏医学》 CAS 2009年第1期24-26,共3页 Acta Medicinae Sinica
关键词 慢性特发性荨麻疹 口服抗组胺药 依从性 chronic idiopathetic urticaria oral antiallergics compliance
  • 相关文献

参考文献4

二级参考文献22

  • 1王晓玲,赵天恩,张喜芹.简体中文版皮肤病生活质量指标信度和效度初探[J].中华流行病学杂志,2004,25(9):791-793. 被引量:211
  • 2Horak F, Stubner UP. Comparative tolerability of second generation antihistamines. Drug Saf, 1999, 20: 355-401.
  • 3Gelfand EW, Appajosyula S, Meeves S. Anti-inflammatory activity of H1-R receptor antagonists: review of recent experimental research. Curr Med Res Opin, 2004, 20: 73-81.
  • 4Kawashima M, Harada S, Tango T. Review of fexofenadine in the treatment of chronic idiopathic urticaria. Int J Dermatol, 2002, 41:701-781.
  • 5Ring J, Hein R, Gauger A, et al. Once-R daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-R blind, placebo-R controlled study. Int J Dermatol, 2001, 40: 72-76.
  • 6Valk PJ, Van Roon DB, Simons RM, et al. Desloratadine shows no effect on performance during 6 h at 8,000 ft simulated cabin altitude. Aviat Space Environ Med, 2004, 75: 433-438.
  • 7Henz BM. The pharmacologic profile of desloratadine: a review. Allergy, 2001, 56(Suppl 65): 7-13.
  • 8Di Lorenzo G, Pacor ML, Mansueto P, et al. Randomized placebo-R controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol, 2004,114: 619-625.
  • 9Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-R blind, placebo-R controlled, crossover clinical study. J Allergy Clin Immunol,2002, 110: 484-488.
  • 10Loria MP, Dambra PP, D'Oronzio L, et al. Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative.Immunopharmacol Immunotoxicol, 2001, 23: 205-213.

共引文献27

同被引文献12

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部